IP Library Granted Patent US 7,850,974
Granted Patent B2
US 7,850,974 · App. 12/575,909 · Granted Dec 14, 2010

Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby

Assignees: The Texas A&M University System; Inhibitex, Inc.; The UAB Research Foundation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,850,974
App. No.
12/575,909
Granted
Dec 14, 2010
Kind
B2
Abstract

A bioinformatic method for identifying and isolating proteins and peptides with MSCRAMM®-like characteristics from Gram positive bacteria, such as Enterococcus, Staphylococcus, Streptococcus and Bacillus bacteria, and proteins and peptides obtained thereby are provided which can be utilized in methods to prevent and treat infections caused by Gram-positive bacteria. The method involves identifying from sequence information those proteins with a putative C-terminal LPXTG (SEQ ID NO:1) cell wall sorting signal and other structural similarities to MSCRAMM® proteins having the LPXTG-anchored cell wall proteins. The MSCRAMM® proteins and immunogenic regions therein that are identified and isolated using the present invention may be useful in the diagnosis, treatment or prevention of Gram positive bacterial infections.

Claims (4)

1. A method of raising an immune response in a human or animal patient comprising administering to the human or animal patient an effective amount of an isolated protein comprising the amino acid sequence of SEQ ID NO: 9.

2. A method of eliciting an immune response in a human or animal comprising administering to said human or animal an immunologically effective amount of an isolated protein comprising the amino acid sequence of SEQ ID NO: 9.

3. A method of raising an immune response in a human or animal patient comprising administering to the human or animal patient an effective amount of an isolated peptide comprising the amino acid sequence of amino acids 63-1067 of SEQ ID NO: 9.

4. A method of eliciting an immune response in a human or animal comprising administering to said human or animal an immunologically effective amount of an isolated peptide comprising the amino acid sequence of amino acids 63-1067 of SEQ ID NO: 9.

Assignments (1)
CONFIRMATORY LICENSE Recorded Apr 9, 2018
From: TEXAS A&M UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 045860/0383 →
Continuity (3)
Division 1066180900 · Sep 15, 2003
Provisional Application 6041030300 · Sep 13, 2002
Related Publication 20100068220A1 · Mar 18, 2010